AKT1 and hepatocellular carcinoma: Thus, we further performed a systematic experiments to validate the regulatory effect of a candidate miRNA targeting AKT1-miR-149 on AKT1-mTOR axis, and its involvement in hepatocarcinogenesis and clinical progression of HCC.